Souvislosti mezi léčbou canagliflozinem a rizikem amputací v programu CANVAS

Abstrakt

Souhrn s komentářem. Citace: Matthews DR, Li Q, Perkovic V, Mahaffey KW, et al.

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS program. Diabetologia 2019 Jun; 62/6): 926-938

Klíčová slova

• canagliflozin
• CANVAS